(November 6, 2007, Las Vegas, NV) The debilitating symptoms of menopause, which is caused by a drop in estrogen levels, are a major health concern for women in the U.S. between the ages of 45 and 60 and for millions of women who continue to suffer from these symptoms in their post-menopausal years.
In a major clinical trial involving 389 participants, genistein, a key isoflavone found in soy, was shown to relieve these symptoms in menopausal women. The randomized, double-blind, placebo-controlled study, whose findings were published in a 2007 issue (Volume 14, No. 4) of Menopause: The Journal of the North American Menopause Society, showed a significant reduction in the number of menopausal symptoms among women taking genistein over a 12-month period.
DSM Nutritional Products has utilized a patented process to create BONISTEIN®, a pure, non-soy genistein that, according to scientific studies, supports natural processes that alleviate menopausal symptoms.
Ideal for many types of supplement formulations, BONISTEIN® is a natural new way for dietary supplement manufacturers to meet women’s unmet need for products that relieve menopausal symptoms. BONISTEIN® is non-GMO and completely allergen-free and provides bone health benefits beyond those offered by calcium, giving consumers an important added reason to take BONISTEIN®.
The world’s leading ingredient supplier to dietary supplement manufacturers, DSM Nutritional Products has an international network of technical service, production and distribution facilities, as well as a major sales and marketing presence, in more than 100 countries. In addition to its vast ingredient portfolio, DSM provides unparalleled processing and manufacturing expertise in developing innovative formulations that provide optimum performance and health appeal.
For more information, please contact DSM Nutritional Products, Inc., at 45 Waterview Boulevard, Parsippany, NJ, 07054-1298. Phone: 1-800-526-0189. Website: www.nutraaccess.com